Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study
Borja Quiroga, María José Soler, Alberto Ortíz, Carlos Jesús Jaravaca Mantecón et autres
ABSTRACT Background Patients on hemodialysis are at high-risk for complications derived from coronavirus disease 2019 (COVID-19). The present analysis evaluated the impact of a booster vaccine dose and breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on humoral immunity 3 months …
es, nl (code pays fourni par la source)
16 citations
Clinical Kidney Journal